干扰素治疗小儿呼吸道感染的研究

目的观察干扰素治疗小儿呼吸道感染的疗效。方法将90例呼吸道感染的小儿随机分成3组,在对症治疗基础上,A组静脉点滴利巴韦林10mg/(kg·d),B组肌注干扰素10μg,1次/d,C组空气压缩泵雾化吸入干扰素10μg,1次/d,观察3组的病情变化。结果C组咳嗽、发热、喘憋及肺部体征好转时间均较A组明显缩短(P<0.01),B组与C组疗效无显著性差异。结论干扰素治疗小儿呼吸道感染疗效确切,值得推广。     

喜炎平注射液联合维生素K3治疗小儿秋季腹泻的疗效观察

目的观察喜炎平与维生素K3联合治疗小儿秋季腹泻的疗效.方法将89例秋季腹泻患儿随机分为2组.治疗组采用喜炎平与维生素K3联合治疗,对照组则采用利巴韦林治疗,疗程5d.结果治疗组的总有效率为93.3%,显著优于对照组的65.9%(X2=10.37,P＜0.01).结论喜炎平与维生素K3联合治疗小儿秋季腹泻值得进一步推广.     

Endoscopic photographic comparison of drug delivery by ear-drops and by aerosol spray

The Otomize (Stafford-Miller Ltd) aerosol spray is a new device for delivering topical ear medication in otitis externa. Both the manufacturers and a recent study have claimed that the spray produces better coverage of the external ear canal than do traditional ear-drops. We performed an endoscopic photographic comparison study to investigate this claim. The area of tympanic membrane and ear canal covered with medication was greater in those ears treated with the aerosol (P < 0.001, paired t-test). The ability of the aerosol to deliver drug to the level of the tympanic membrane suggests a possible role for this device in the treatment of chronic otitis media. The technique of endoscopic photography provides an objective and reproducible means of investigating drug delivery systems for otological conditions.     

Demonstration of dilatation of peripheral airways

Summary. To investigate the ability of various lung-function tests to demonstrate dilatation of peripheral airways, ten asthmatics inhaled increasing doses of a f2-agonist by two different and controlled techniques. Low inspiratory flow with a long post-inspi-ratory pause favoured peripheral deposition, and a high inspiratory flow with a short post-inspiratory pause favoured central deposition of drug in the airways. Ordinary spirometry, maximum expiratory flow rates after breathing air as well as a helium-oxygen mixture, a single breath N₂-test and resistance of the respiratory system were obtained before and after each of five terbutaline doses with both inhalation techniques. By using a double-dummy technique, the study could be performed double blinded. Effects were compared at doses giving equal effects on PEF, assumed to represent equal deposition of bronchodilator and effects on central airways. At such ‘iso A PEF doses’, particularly FVC and the slope of phase III of the N₂-test improved more following the slow inhalation technique. It is concluded that changes in those tests reflect dilatation in peripheral airways in asthmatics.,     

大鼠吸入EHFV气溶胶后体内抗原抗体的动态观察

本次试验研究表明:实验大白鼠吸入EHFV气溶胶后第5天部份实验鼠血中即可检测到EHFV抗原,14天后EHF抗原全部消失,病毒血症可持续7天左右;第7天肺组织中可检测到EHF抗原其IF强度和病毒感染滴度亦随感染时间而增高。EHF抗原阳性的肺组织中IgA水平显著高于EHF抗原阴性的肺。肺组织中IgA的增高可能有促进EHFV的感染,这对研究EHFV气溶胶感染提供了一定的科学依据。     

舒喘灵气雾剂治疗毛细支气管炎临床观察

目的 探讨舒喘灵气雾剂对毛细支气管炎的治疗效果。方法 选择106例住院毛细支气管炎患儿随机分为两组,对照组给予常规治疗,治疗组在常规治疗的基础上给予舒喘灵气雾剂,每天3次吸入。疗程结束后,观察毛细支气管炎改善情况。结果 治疗组有效率90％,对照组有效率17.4％,两组对比P<0.01,差异显著。结论 舒喘灵气雾剂对毛细支气管炎治疗效果佳,副作用小,值得推广。     

干扰素病毒唑联合治疗慢性丙型肝炎疗效及干扰素抗体的影响

目的 :研究干扰素与病毒唑联合治疗慢性丙型肝炎疗效及干扰素抗体的影响。方法 :观察组 2 0例采用干扰素 α2b 3MvTiwIH +病毒唑 10 0 0mgQdpo连用 2 4周 ;对照组 3 2例采用干扰素 α2b 3MvTiwiH连用 2 4周。停药后观察 2 4周比较疗效并检测干扰抗体。结果 :观察组完全应答率为 5 0 % ,明显高于对照组 18.7% ;复发率为 2 5 .0 %低于对照组 5 6.3 % (P <0 .0 1)。无反应率均为 2 5 .0 %。且复发与干扰素抗体尤其是中和抗体有关。结论 :观察组疗效优于对照组 ,复发与干扰素抗体尤其是中和抗体有关。     

雾化吸入对新生儿肺炎患儿血氧饱和度的影响

采用动脉血氧饱和度仪对５２例新生儿肺炎患儿，在雾化吸入治疗过程中的动脉血氧饱和度（ＳａＯ２）进行了监测，对比了吸氧与否对ＳａＯ２改变的影响。结查表明：与基础值比较，雾化吸入时患儿的ＳａＯ２显著下降（Ｐ＜０．０１），而雾化吸入同时吸氧者ＳａＯ２无明显变化（Ｐ＞０．０５），但两者比较具有显著性差异（Ｐ＜０．０１）。结果提示雾化吸入可使新生儿肺炎患儿ＳａＯ２下降；同时吸氧，对防止ＳａＯ２的下降有一定作用。     

Comparison of Output Particle Size Distributions from Pressurized Aerosols Formulated as Solutions or Suspensions

The delivery of particles as small as possible (preferably <5 µm) to the respiratory tract should be the aim of those formulating metered dose inhalers (MDIs). This may be facilitated by the formulation of solution, rather than suspension-type, pressurized aerosol units. Two series of MDIs were compared; one contained suspended micronized disodium fluorescein (0.1%, w/v), while the other contained the same concentration of dissolved salicylic acid. Either oleic acid, L--phosphatidylcholine, or sorbitan trioleate was incorporated at 0.15% (w/v) as suspending agent (disodium fluorescein) or solubilizing agent (salicylic acid). The propellant blend was 70% (w/w) Freon 12 and 30% (w/w) Freon 11 in all cases. This exhibited a vapor pressure of 50.6 psig (444.7 kPa) at 21°C. The output particle size distribution of the aerosol reaching the cascade impactor showed a mass median aerodynamic diameter (MMAD) of approximately 4 and 2 µm for the suspension and solution formulations respectively, regardless of the surfactant used. Larger MMADs were observed for solution aerosols formulated with oleic acid (2.32 µm) compared to those containing L--phosphatidylcholine (1.93 µm) or sorbitan trioleate (2.07 µm). Possible reasons for these observations are discussed.